Home > Financial Ratios > MARKSANS PHARMA
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.6812.236.325.185.35

What is the latest EV/Core EBITDA ratio of MARKSANS PHARMA ?

The latest EV/Core EBITDA ratio of MARKSANS PHARMA is 15.68 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202515.68
Mar202412.23
Mar20236.32
Mar20225.18
Mar20215.35

How is EV/Core EBITDA of MARKSANS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 15.68
28.21
Mar2024 12.23
93.51
Mar2023 6.32
22.01
Mar2022 5.18
-3.18
Mar2021 5.35 -

Other Financial Ratios of MARKSANS PHARMA


Compare EV/Core EBITDA ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹9,592.0 Cr -2.8% 17.9% -14.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.8%

17.9%

-14.7%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses